Clinical Trial Update: Safety and Efficacy Study of Umbilical Mesenchymal Stem Cells for Liver Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

This document outlines a Phase 1/2 clinical trial evaluating umbilical mesenchymal stem cells for liver cirrhosis, sponsored by Alliancells Bioscience Corporati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Umbilical Mesenchymal Stem Cells

Snippet

Sponsor: Alliancells Bioscience Corporation Limited | Conditions: Liver Cirrhosis | Phase 1, Phase 2 | Status: UNKNOWN